Sodium/glucose cotransporter 1 (SGLT1) is a high-affinity Na+-coupled symporter that actively transports D-glucose and D-galactose across the plasma membrane with 2:1 Na+:glucose stoichiometry. SGLT1 is the primary transporter for dietary hexose absorption across the apical brush-border membrane of enterocytes in the small intestine. In kidney, it functions in the S3 segment of proximal tubules for glucose reabsorption, handling approximately 3% of filtered glucose. Additionally serves as a water channel enabling passive water transport. Located at the blood-brain barrier in endothelial cells.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0016324
apical plasma membrane
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation based on phylogenetic inference. SGLT1 apical localization is well-established across mammals. Direct experimental evidence in rat shows SGLT1 at apical membrane in MDCK cells (PMID:11831390), blood-brain barrier endothelial cells (PMID:14986005), and kidney proximal tubule S3 segments (PMID:16204409).
Reason: Core localization for SGLT1 function. Phylogenetic inference is well-supported by multiple direct experimental studies in rat demonstrating apical membrane localization in intestinal epithelium, renal proximal tubules, and brain endothelial cells. The N-terminal domain determines apical targeting (PMID:11831390).
Supporting Evidence:
PMID:11831390
The products of N-terminal deletion clones up to the 19th amino acid were localized at the apical plasma membrane
PMID:14986005
Immunostaining suggested that SGLT1 is located in the luminal membrane of the endothelial cells
file:rat/Slc5a1/Slc5a1-deep-research-falcon.md
model: Edison Scientific Literature
|
|
GO:0016324
apical plasma membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: IEA annotation based on UniProtKB/Swiss-Prot subcellular location mapping. Redundant with IBA and IDA annotations for same term.
Reason: While redundant with IBA annotation, this IEA represents valid automated inference from UniProt subcellular location annotation. Duplicates are acceptable in GO as they represent independent evidence paths. Core localization is correct.
|
|
GO:0016324
apical plasma membrane
|
IDA
PMID:14986005 Localization of the Na+-D-glucose cotransporter SGLT1 in the... |
ACCEPT |
Summary: Direct experimental evidence from immunohistochemistry in rat brain capillaries showing SGLT1 in luminal (apical) membrane of blood-brain barrier endothelial cells.
Reason: High-quality experimental evidence demonstrating apical localization in brain endothelial cells. The study showed immunoreactivity in intracerebral capillaries with staining in the luminal membrane.
Supporting Evidence:
PMID:14986005
Immunostaining suggested that SGLT1 is located in the luminal membrane of the endothelial cells and in intracellular vesicles
|
|
GO:0016324
apical plasma membrane
|
IDA
PMID:11831390 The apical localization of SGLT1 glucose transporter is dete... |
ACCEPT |
Summary: Direct experimental evidence from MDCK cell localization studies showing rat SGLT1 localizes to apical plasma membrane. N-terminal deletion analysis identified apical targeting signals.
Reason: High-quality experimental evidence. Study used rat SGLT1 expressed in MDCK cells and demonstrated apical localization, with identification of the N-terminal targeting domain.
Supporting Evidence:
PMID:11831390
SGLT1, an isoform of Na+-dependent glucose cotransporters, is localized at the apical plasma membrane in the epithelial cells of the small intestine and the kidney
|
|
GO:0016324
apical plasma membrane
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation transferred from other mammalian species by RGD. Redundant with multiple direct experimental annotations (IDA) for rat SGLT1.
Reason: Valid ortholog transfer that is consistent with direct rat experimental evidence. Duplicates are acceptable as independent evidence paths.
|
|
GO:0005886
plasma membrane
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: IBA annotation for plasma membrane localization. This is a parent term of apical plasma membrane (GO:0016324) which is the more specific correct localization.
Reason: While technically correct, this is less specific than apical plasma membrane. The more specific term GO:0016324 better captures SGLT1's polarized localization. Acceptable to retain as it captures the broader membrane context.
|
|
GO:0005886
plasma membrane
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: ISO annotation transferred from mammalian orthologs. Less specific than apical plasma membrane annotations.
Reason: Valid but less specific than apical plasma membrane. The more specific term GO:0016324 is preferred for capturing SGLT1's polarized epithelial localization.
|
|
GO:0031526
brush border membrane
|
IDA
PMID:14986005 Localization of the Na+-D-glucose cotransporter SGLT1 in the... |
ACCEPT |
Summary: Brush border membrane localization is well supported for intestinal SGLT1, but PMID:14986005 itself focuses on brain capillary localization. Accept the term based on direct intestinal apical membrane evidence from other sources.
Reason: The brush border membrane term is appropriate for intestinal SGLT1, even though PMID:14986005 is likely a misassigned reference. Experimental data from intestinal apical membrane preparations support this localization.
Supporting Evidence:
PMID:17272350
Western blotting showed that in each case there was a significant decrease in apical GLUT2 level, but no change in SGLT1 level.
|
|
GO:0031526
brush border membrane
|
IDA
PMID:17272350 Apical GLUT2 and Cav1.3: regulation of rat intestinal glucos... |
ACCEPT |
Summary: Direct experimental evidence showing SGLT1 at intestinal brush border membrane in rat jejunum. Western blotting confirmed SGLT1 presence in apical membrane preparations.
Reason: High-quality experimental evidence demonstrating SGLT1 at brush border membrane of rat intestinal epithelium. This is a core localization for intestinal glucose absorption.
Supporting Evidence:
PMID:17272350
Western blotting showed that in each case there was a significant decrease in apical GLUT2 level, but no change in SGLT1 level
|
|
GO:0005903
brush border
|
ISO
GO_REF:0000121 |
MODIFY |
Summary: ISO annotation for brush border localization. Brush border (GO:0005903) is the parent of brush border membrane (GO:0031526). The more specific membrane term is more accurate for a transmembrane transporter.
Reason: For a transmembrane transporter, the more specific term brush border membrane (GO:0031526) is more appropriate than the general brush border term.
Proposed replacements:
brush border membrane
|
|
GO:0016020
membrane
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: Very general IEA annotation based on InterPro record mapping. SGLT1 has many more specific membrane annotations (apical plasma membrane, brush border membrane).
Reason: This is too general to be informative. SGLT1 has specific annotations to apical plasma membrane and brush border membrane that are much more informative. While technically correct, this adds no useful information.
|
|
GO:0043226
organelle
|
IDA
PMID:14986005 Localization of the Na+-D-glucose cotransporter SGLT1 in the... |
MODIFY |
Summary: The paper mentions intracellular vesicles containing SGLT1 in brain endothelial cells. However, 'organelle' is extremely vague and should be more specific.
Reason: The paper specifically mentions intracellular vesicles, not generic organelles. A more specific term would be appropriate if we want to capture this localization.
Proposed replacements:
cytoplasmic vesicle
Supporting Evidence:
PMID:14986005
Immunostaining suggested that SGLT1 is located in the luminal membrane of the endothelial cells and in intracellular vesicles
|
|
GO:0016323
basolateral plasma membrane
|
TAS
PMID:14986005 Localization of the Na+-D-glucose cotransporter SGLT1 in the... |
REMOVE |
Summary: Questionable annotation. PMID:14986005 specifically shows SGLT1 in the LUMINAL (apical) membrane of brain endothelial cells, not basolateral. This appears to be an error in annotation.
Reason: The cited paper explicitly states SGLT1 is in the luminal membrane, which is the apical/blood-facing side of brain capillary endothelium, not basolateral. SGLT1 is canonically an apical transporter; basolateral glucose exit is mediated by GLUT2.
Supporting Evidence:
PMID:14986005
Immunostaining suggested that SGLT1 is located in the luminal membrane of the endothelial cells
|
|
GO:0005911
cell-cell junction
|
IDA
PMID:17090404 Asymmetric subcellular distribution of glucose transporters ... |
KEEP AS NON CORE |
Summary: Direct experimental evidence showing SGLT1 clusters at cell-cell junctions in arterial endothelium. High-density clusters found in proximity to cell-to-cell junctions.
Reason: Valid experimental finding in endothelial cells showing SGLT1 clustering near cell-cell junctions. This represents a secondary localization pattern in vascular endothelium, not the primary physiological localization in intestine/kidney.
Supporting Evidence:
PMID:17090404
Clusters of the glucose transporter isoforms were found at a high density in proximity to the cell-to-cell junctions
|
|
GO:0005769
early endosome
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: ISO annotation from mammalian orthologs. SGLT1 trafficking through endosomal compartments is plausible for membrane protein recycling.
Reason: Likely reflects trafficking/recycling rather than steady-state functional localization. Not a core localization but may be valid for protein turnover.
|
|
GO:0048471
perinuclear region of cytoplasm
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: ISO annotation from orthologs. May reflect biosynthetic pathway localization (ER/Golgi) rather than functional localization.
Reason: Likely reflects biosynthetic pathway (ER/Golgi in perinuclear region) rather than functional localization. Not a core localization for SGLT1 function.
|
|
GO:0005412
D-glucose:sodium symporter activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Core molecular function of SGLT1 - IBA based on phylogenetic inference. This is the defining activity of the SGLT1 transporter family.
Reason: This is THE core molecular function of SGLT1. The transporter catalyzes 2 Na+ : 1 D-glucose cotransport as established across all species. UniProt confirms this catalytic activity with Rhea reaction annotation.
Supporting Evidence:
PMID:15829715
the renal brush-border membrane Na+/glucose co-transporter-1 (SGLT1) is a molecular target for Cd2+ toxicity
|
|
GO:0005412
D-glucose:sodium symporter activity
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation from mammalian orthologs. Consistent with direct rat evidence.
Reason: Core molecular function, well-supported by direct rat experimental evidence and consistent phylogenetic conservation.
|
|
GO:0005412
D-glucose:sodium symporter activity
|
IDA
PMID:15829715 The endogenous CXXC motif governs the cadmium sensitivity of... |
ACCEPT |
Summary: Direct experimental evidence showing rat SGLT1 Na+/glucose cotransport activity. Study used methyl-D-glucopyranoside uptake assays in SGLT1-expressing cells.
Reason: High-quality direct experimental evidence demonstrating the core molecular function in rat SGLT1.
Supporting Evidence:
PMID:15829715
Cd2+ acted as a noncompetitive, partial inhibitor of methyl-D-glucopyranoside uptake in vesicles from COS-7 cells transiently expressing SGLT1
|
|
GO:0005412
D-glucose:sodium symporter activity
|
TAS
PMID:11831390 The apical localization of SGLT1 glucose transporter is dete... |
ACCEPT |
Summary: TAS annotation from paper on SGLT1 apical localization. Paper discusses SGLT1 as glucose transporter but main focus is localization not transport activity.
Reason: The paper refers to SGLT1's known function as Na+-dependent glucose cotransporter. While the experimental focus is localization, the stated function is accurate.
Supporting Evidence:
PMID:11831390
SGLT1, an isoform of Na+-dependent glucose cotransporters, is localized at the apical plasma membrane
|
|
GO:0015371
galactose:sodium symporter activity
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation for galactose transport. SGLT1 transports both D-glucose and D-galactose with similar affinity - this is well-established in the literature.
Reason: Core molecular function. SGLT1 transports D-galactose as well as D-glucose, both with high affinity. UniProt catalytic activity annotation confirms this. PMID:16204409 used galactose uptake to measure SGLT1 activity.
Supporting Evidence:
PMID:16204409
The phlorizin-sensitive uptake of d-[(3)H]galactose in BBM vesicles
|
|
GO:0015371
galactose:sodium symporter activity
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation based on sequence similarity. Consistent with ISO annotation and UniProt functional annotation.
Reason: Core molecular function. Galactose transport by SGLT1 is well-established and conserved across species.
|
|
GO:0005372
water transmembrane transporter activity
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation for water transport. SGLT1 functions as a water channel with high water conductivity comparable to aquaporins, enabling passive water transport.
Reason: Core molecular function. UniProt describes SGLT1 as having high water conductivity comparable to aquaporins, enabling passive water transport in response to osmotic gradients created during sugar/Na+ uptake.
|
|
GO:0005372
water transmembrane transporter activity
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation from orthologs for water transport activity.
Reason: Core molecular function. Water transport by SGLT1 is well-documented and important for transepithelial water permeability in intestine.
|
|
GO:0055056
D-glucose transmembrane transporter activity
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: ISO annotation for general glucose transporter activity. This is less specific than D-glucose:sodium symporter activity which captures the coupling mechanism.
Reason: While correct, this is less informative than D-glucose:sodium symporter activity (GO:0005412) which specifies the sodium-coupling mechanism that defines SGLT1.
|
|
GO:0015151
alpha-glucoside transmembrane transporter activity
|
ISO
GO_REF:0000121 |
MARK AS OVER ANNOTATED |
Summary: ISO annotation for alpha-glucoside transport. SGLT1 transports glucose (an alpha-glucoside in its cyclic form), but this term is typically used for disaccharide transport (e.g., maltose, sucrose). May be an over-annotation.
Reason: SGLT1 transports monosaccharides (glucose, galactose), not alpha-glucosides like maltose or sucrose. The more accurate term is D-glucose:sodium symporter activity. This term implies transport of glycosides/disaccharides which is not the primary function.
|
|
GO:0015293
symporter activity
|
IEA
GO_REF:0000043 |
MARK AS OVER ANNOTATED |
Summary: IEA annotation from UniProtKB keyword mapping. Very general term.
Reason: Too general. The specific term D-glucose:sodium symporter activity (GO:0005412) is much more informative and captures the actual substrate specificity.
|
|
GO:0022857
transmembrane transporter activity
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: Very general IEA annotation from InterPro mapping.
Reason: Far too general to be informative. Specific molecular function annotations (D-glucose:sodium symporter activity) provide the relevant information.
|
|
GO:0008324
monoatomic cation transmembrane transporter activity
|
IEA
GO_REF:0000117 |
MARK AS OVER ANNOTATED |
Summary: IEA from ARBA machine learning. SGLT1 uses Na+ gradient to drive glucose transport but is not primarily a cation transporter - it is a sugar transporter.
Reason: Misleading annotation. While SGLT1 translocates Na+ ions, it is primarily a sugar transporter that uses the Na+ gradient as driving force. The sodium transport is coupled to/incidental to the primary glucose transport function.
|
|
GO:0001951
intestinal D-glucose absorption
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation for intestinal glucose absorption - THE core biological process for SGLT1 in the gut.
Reason: Core biological process. SGLT1 is the primary transporter for dietary glucose absorption across enterocyte brush border membrane.
Supporting Evidence:
PMID:17272350
We have proposed a model of intestinal glucose absorption in which transport by SGLT1 induces rapid insertion and activation of GLUT2
|
|
GO:0001951
intestinal D-glucose absorption
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation from orthologs. Consistent with direct rat evidence.
Reason: Core biological process, well-supported by rat experimental evidence.
|
|
GO:0001951
intestinal D-glucose absorption
|
TAS
PMID:15829715 The endogenous CXXC motif governs the cadmium sensitivity of... |
ACCEPT |
Summary: TAS annotation. The paper's main focus is cadmium inhibition of SGLT1, but mentions intestinal glucose absorption as established SGLT1 function.
Reason: Core biological process. While paper focuses on cadmium effects, it references SGLT1's role in intestinal glucose absorption.
Supporting Evidence:
PMID:15829715
2005 Apr 13. The endogenous CXXC motif governs the cadmium sensitivity of the renal Na+/glucose co-transporter.
|
|
GO:0035623
renal D-glucose absorption
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for renal glucose reabsorption. SGLT1 handles glucose reabsorption in S3 segment of proximal tubule (minor fraction, ~3% of total).
Reason: Core biological process. PMID:16204409 directly demonstrates SGLT1 in rat kidney S3 proximal tubule segments with functional glucose transport activity.
Supporting Evidence:
PMID:16204409
SGLT1 (SLC5A1) mediates a part of glucose and galactose reabsorption in the mammalian proximal tubule
PMID:16204409
the expression of SGLT1 is represented by a 75-kDa protein localized largely in the PT S3 segments
|
|
GO:0035623
renal D-glucose absorption
|
ISS
GO_REF:0000024 |
ACCEPT |
Summary: ISS annotation from sequence similarity. Consistent with direct rat evidence.
Reason: Core biological process, well-supported by direct rat experimental evidence.
|
|
GO:0035623
renal D-glucose absorption
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation from orthologs. Consistent with IBA and direct rat evidence.
Reason: Core biological process with strong experimental support in rat.
|
|
GO:0098708
D-glucose import across plasma membrane
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: IBA annotation for glucose import. Accurate description of SGLT1's transport direction (import into cell).
Reason: Core biological process. SGLT1 imports glucose from lumen into epithelial cells. This is a fundamental aspect of its transport function.
|
|
GO:0098708
D-glucose import across plasma membrane
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation from orthologs. Consistent with IBA annotation.
Reason: Core biological process describing the import direction of SGLT1-mediated glucose transport.
|
|
GO:1904659
D-glucose transmembrane transport
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation for glucose transmembrane transport.
Reason: Core biological process. This is the primary transport function of SGLT1.
|
|
GO:1904659
D-glucose transmembrane transport
|
TAS
PMID:11831390 The apical localization of SGLT1 glucose transporter is dete... |
ACCEPT |
Summary: TAS annotation. Paper focuses on localization but references SGLT1's glucose transport function.
Reason: Core biological process. While paper's experimental focus is localization, SGLT1's glucose transport function is accurately referenced.
Supporting Evidence:
PMID:11831390
SGLT1 glucose transporter...plays a pivotal role in the absorption and reabsorption of sugars
|
|
GO:0015757
galactose transmembrane transport
|
IEA
GO_REF:0000108 |
ACCEPT |
Summary: IEA annotation based on logical inference. SGLT1 transports galactose with similar affinity to glucose - this is experimentally demonstrated in rat.
Reason: Core biological process. Galactose transport by SGLT1 is well-established. PMID:16204409 used galactose uptake assays to measure rat SGLT1 activity.
Supporting Evidence:
PMID:16204409
SGLT1 (SLC5A1) mediates a part of glucose and galactose reabsorption in the mammalian proximal tubule
|
|
GO:0050892
intestinal absorption
|
TAS
PMID:16204409 Rat renal glucose transporter SGLT1 exhibits zonal distribut... |
ACCEPT |
Summary: TAS annotation. The paper primarily focuses on kidney, though it mentions intestinal absorption as SGLT1 function.
Reason: Core biological process. SGLT1's role in intestinal absorption is well-established.
Supporting Evidence:
PMID:16204409
SGLT1 (SLC5A1) mediates a part of glucose and galactose reabsorption in the mammalian proximal tubule
|
|
GO:0050892
intestinal absorption
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation from orthologs. Consistent with known SGLT1 function.
Reason: Core biological process for SGLT1 in the gut.
|
|
GO:0035377
transepithelial water transport
|
ISO
GO_REF:0000121 |
ACCEPT |
Summary: ISO annotation for water transport function. SGLT1 acts as a water channel with high conductivity comparable to aquaporins.
Reason: Core biological process. SGLT1's water transport activity is important for intestinal water absorption coupled to glucose/Na+ uptake.
|
|
GO:0098719
sodium ion import across plasma membrane
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: ISO annotation for sodium import. SGLT1 couples 2 Na+ import per glucose.
Reason: While technically accurate (SGLT1 imports 2 Na+ per glucose), sodium transport is secondary to the primary function of glucose transport. The Na+ gradient drives glucose uptake rather than being the primary transported substrate.
|
|
GO:0006814
sodium ion transport
|
IEA
GO_REF:0000043 |
KEEP AS NON CORE |
Summary: IEA annotation from UniProtKB keyword mapping.
Reason: While Na+ is cotransported with glucose, this annotation may give the misleading impression that SGLT1 is primarily a sodium transporter. The primary function is glucose transport using the Na+ gradient.
|
|
GO:0006811
monoatomic ion transport
|
IEA
GO_REF:0000043 |
MARK AS OVER ANNOTATED |
Summary: Very general IEA annotation for ion transport.
Reason: Too general and misleading. SGLT1 is a sugar transporter that cotransports sodium, not primarily an ion transporter.
|
|
GO:0055085
transmembrane transport
|
IEA
GO_REF:0000002 |
MARK AS OVER ANNOTATED |
Summary: Very general IEA annotation from InterPro mapping.
Reason: Far too general to be informative. Specific process annotations provide the relevant information about SGLT1 function.
|
|
GO:0150104
transport across blood-brain barrier
|
ISO
GO_REF:0000121 |
KEEP AS NON CORE |
Summary: ISO annotation for BBB transport. Rat experimental evidence shows SGLT1 in brain capillary endothelium with upregulation after ischemia.
Reason: Valid annotation supported by rat experimental evidence (PMID:14986005). Not a core function (intestine/kidney are primary sites) but represents an established secondary physiological role.
Supporting Evidence:
PMID:14986005
The data suggest that SGLT1 participates in transport of D-glucose across the blood-brain barrier
|
|
GO:1902476
chloride transmembrane transport
|
ISO
NOT
GO_REF:0000121 |
UNDECIDED |
Summary: ISO annotation for chloride transport. This is unexpected - SGLT1 is not known as a chloride transporter. May be an erroneous annotation.
Reason: SGLT1 is a Na+/glucose symporter, not a chloride transporter. The basis for this annotation is unclear. Would need to trace the original evidence from the ortholog to evaluate. Marking as undecided pending clarification.
|
|
GO:0000017
alpha-glucoside transport
|
ISO
GO_REF:0000121 |
MARK AS OVER ANNOTATED |
Summary: ISO annotation for alpha-glucoside transport. SGLT1 transports monosaccharides, not glucosides (which typically refers to disaccharides).
Reason: SGLT1 transports D-glucose and D-galactose (monosaccharides), not alpha-glucosides like maltose or sucrose. This term is misleading for SGLT1's actual substrate specificity.
|
|
GO:0009758
carbohydrate utilization
|
IDA
PMID:25592016 Induction of histone H3K4 methylation at the promoter, enhan... |
MODIFY |
Summary: IDA annotation from study on dietary regulation of Sglt1 gene expression. The paper shows epigenetic regulation (H3K4 methylation) of Sglt1 in response to high-starch diet, not direct SGLT1 involvement in carbohydrate utilization.
Reason: The paper demonstrates transcriptional regulation of Sglt1 by diet, not a direct role for SGLT1 protein in carbohydrate utilization. The appropriate process would be related to glucose absorption/transport, not utilization.
Proposed replacements:
intestinal D-glucose absorption
Supporting Evidence:
PMID:25592016
Feeding rats the high-starch/low-fat diet induced mono-, di-, and trimethylation of histone H3K4 on the promoter and transcribed regions of the Si and Sglt1 genes
|
|
GO:0001656
metanephros development
|
ISO
GO_REF:0000121 |
UNDECIDED |
Summary: ISO annotation for kidney development. SGLT1 is a glucose transporter that is expressed during kidney development but is not known to have a developmental signaling role.
Reason: The basis for this developmental annotation is unclear. SGLT1 may be expressed during kidney development but is primarily a glucose transporter, not a developmental regulator. Would need to evaluate the original ortholog evidence.
|
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Plan status and verification
We verified the target identity: Slc5a1 encodes sodium/glucose cotransporter 1 (SGLT1) in Rattus norvegicus. The collected evidence consistently describes a sodium:solute symporter (SSF family) that mediates 2 Na+ per glucose cotransport, is apically localized in intestinal enterocytes and in the S3 (late) segment of the proximal tubule, and is detected in heart—aligning with the UniProt P53790 annotation and SSF family/domain context (azizogli2023comparisonofsglt1 pages 3-5, mroueh2024preclinicalandtranslationalb pages 84-88, mroueh2024preclinicalandtranslational pages 84-88).
Executive summary
SGLT1 (Slc5a1) is a high‑affinity Na+-coupled symporter for D‑glucose and D‑galactose with 2:1 Na+:glucose stoichiometry. In rat, it operates at the apical (brush‑border) membrane of small‑intestinal enterocytes to absorb dietary hexoses and in the S3 segment of the renal proximal tubule to reclaim a minor fraction of filtered glucose; it is also present in cardiomyocytes and other cardiac cells. Mechanistically, it follows an alternating‑access transport cycle characteristic of SSF transporters. SGLT1 is dynamically regulated by luminal carbohydrate and apical β2‑adrenergic receptor signaling (via PKA) that rapidly increases apical SGLT1 availability in rat intestine. Perturbations of SGLT1 function contribute to diarrheal pathophysiology and may shape renal compensation when SGLT2 is inhibited. Translationally, dual SGLT1/2 inhibitors (e.g., sotagliflozin) and intestine‑restricted SGLT1 inhibitors (e.g., LX2761) leverage these mechanisms but can cause GI adverse events when intestinal SGLT1 is inhibited. Key quantitative features and up‑to‑date references are summarized below (paulussen2023theβ2adrenergicreceptor pages 11-14, azizogli2023comparisonofsglt1 pages 3-5, rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70, kharve2024impactofdrugmediated pages 4-7).
Key concepts and definitions
• Primary function and substrates: SGLT1 is a Na+-dependent symporter for D‑glucose and D‑galactose, not fructose; it is characterized as high‑affinity/low‑capacity relative to SGLT2 (human/rodent consensus). The canonical stoichiometry is 2 Na+ per glucose, supporting uphill sugar transport (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; Frontiers in Molecular Biosciences, 2025, https://doi.org/10.3389/fmolb.2025.1668400) (azizogli2023comparisonofsglt1 pages 3-5, kaijage2025molecularmechanismsand pages 2-3).
• Transport mechanism: SGLT1 conforms to the sodium:solute symporter (SSF) family’s Na+-coupled alternating‑access mechanism; structural advances in family members (SGLT2) and comparative analyses illuminate conserved motifs and gating transitions relevant to SGLT1 (Frontiers in Molecular Biosciences, 2025, https://doi.org/10.3389/fmolb.2025.1668400) (kaijage2025molecularmechanismsand pages 2-3).
• Localization in rat tissues: SGLT1 is apical in small‑intestinal enterocytes (brush border), localized to the late proximal tubule (S3) in kidney (contributing a minor fraction of renal glucose reabsorption), and expressed in cardiomyocytes and other cardiac cell types (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; preclinical/translational review, 2024) (azizogli2023comparisonofsglt1 pages 3-5, mroueh2024preclinicalandtranslationalb pages 84-88, mroueh2024preclinicalandtranslational pages 84-88, mroueh2024preclinicalandtranslationala pages 84-88).
Recent developments and latest research (2023–2024 emphasis)
• Apical β2‑AR control of rat intestinal SGLT1: In everted rat intestinal sacs, epinephrine (10 μM) increased luminal‑to‑tissue glucose accumulation from 440 ± 132 to 833 ± 255 μM; this was prevented by the β2‑AR antagonist ICI 118,551 and was >90% suppressed by SGLT inhibitors (phlorizin 100 μM; LX4211 2 μM). Colchicine blocked the epinephrine effect without altering basal uptake, indicating β2‑AR–PKA‑dependent translocation of SGLT1 to the brush border (Frontiers in Cell and Developmental Biology, 2023, https://doi.org/10.3389/fcell.2022.1041930) (paulussen2023theβ2adrenergicreceptor pages 11-14).
• Segmental intestinal regulation and incretin coupling: Recent syntheses highlight SGLT1’s proximal>distal intestinal gradient and its role in glucose‑dependent GLP‑1/GIP secretion, with pharmacologic or genetic inhibition blunting incretin responses; SGLT1 expression is responsive to luminal carbohydrate (Rottenberger, 2024) (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70).
• Kidney physiology context and distribution of work between SGLTs: Contemporary analyses reiterate that early proximal SGLT2 handles the large majority of filtered glucose and SGLT1 in late S2/S3 reclaims the remainder; estimates include ~97% via SGLT2 vs ~3% via SGLT1 (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143) (azizogli2023comparisonofsglt1 pages 3-5).
• Intestinal transporter safety and drug interactions: A 2024 scoping analysis emphasizes that intestinal SGLT1 inhibition (e.g., dual SGLT1/2 inhibitors) can cause carbohydrate malabsorption and diarrhea; it catalogues intestinal transporter roles and potential unintended nutrient disposition changes (Pharmaceutics, 2024, https://doi.org/10.3390/pharmaceutics16040447) (kharve2024impactofdrugmediated pages 4-7).
Current applications and real‑world implementations
• Dual SGLT1/2 inhibition: Sotagliflozin (LX4211) improves glycemic control by combining renal glucose excretion (SGLT2) with reduced postprandial intestinal absorption (SGLT1), but GI adverse effects reflect on‑target intestinal SGLT1 inhibition (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; Pharmaceutics, 2024, https://doi.org/10.3390/pharmaceutics16040447) (azizogli2023comparisonofsglt1 pages 3-5, kharve2024impactofdrugmediated pages 4-7).
• Intestine‑restricted SGLT1 inhibition: LX2761 (nonabsorbable) is designed to limit systemic exposure and confine SGLT1 inhibition to the gut, aiming to reduce postprandial glycemia while mitigating systemic effects; reviews summarize its rationale and emergence (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; Pharmaceutics, 2024, https://doi.org/10.3390/pharmaceutics16040447) (azizogli2023comparisonofsglt1 pages 3-5, kharve2024impactofdrugmediated pages 4-7).
• Selectivity ranking among marketed SGLT2 inhibitors: PBPK analysis indicates dual inhibitor sotagliflozin has the highest SGLT1 inhibition among tested agents, followed by ertugliflozin and empagliflozin (Frontiers in Pharmacology, 2023, https://doi.org/10.3389/fphar.2023.1142003) (kharve2024impactofdrugmediated pages 4-7).
Expert opinions and analysis
• Integrative positioning of SGLT1 in cardiorenal‑metabolic axis: Reviews synthesize that SGLT1 is high‑affinity/low‑capacity, localized to intestinal brush border and renal S3, and present in heart; SGLT1’s role becomes more prominent when SGLT2 is inhibited, with potential downstream compensations in late proximal segments (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; preclinical/translational review, 2024) (azizogli2023comparisonofsglt1 pages 3-5, mroueh2024preclinicalandtranslationalb pages 84-88, mroueh2024preclinicalandtranslational pages 84-88).
• Intestinal endocrine–absorptive crosstalk: Contemporary analyses underscore SGLT1’s involvement in enteroendocrine sensing and incretin secretion, framing therapy designs (e.g., intestine‑restricted SGLT1 inhibitors) to modulate postprandial excursions while considering GI tolerability (Rottenberger, 2024) (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70).
Relevant statistics and quantitative data
• Stoichiometry: SGLT1 couples 2 Na+ to 1 glucose (vs SGLT2’s 1:1), enabling higher uphill transport capability per cycle (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143) (azizogli2023comparisonofsglt1 pages 3-5).
• Renal fractional reabsorption: Approximate division of filtered glucose reabsorption: ~97% SGLT2 (S1/S2) vs ~3% SGLT1 (late S2/S3) (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143) (azizogli2023comparisonofsglt1 pages 3-5).
• Rat intestinal β2‑AR regulation experiment: Epinephrine (10 μM) approximately doubled SGLT‑mediated glucose accumulation in rat everted sacs (440 ± 132 → 833 ± 255 μM), blocked by β2‑AR antagonism and SGLT inhibitors; colchicine abolished the epinephrine effect, consistent with SGLT1 translocation (Frontiers in Cell and Developmental Biology, 2023, https://doi.org/10.3389/fcell.2022.1041930) (paulussen2023theβ2adrenergicreceptor pages 11-14).
• Clinical pharmacology context: Dual SGLT1/2 inhibition can provoke diarrhea due to unabsorbed intestinal carbohydrate and osmotic water retention when SGLT1 is inhibited (Pharmaceutics, 2024, https://doi.org/10.3390/pharmaceutics16040447) (kharve2024impactofdrugmediated pages 4-7).
Detailed synthesis by topic
1) Primary function, substrates, stoichiometry, mechanism
SGLT1 (Slc5a1) is the apical Na+-dependent glucose/galactose symporter responsible for active uptake against the luminal gradient, with 2 Na+ per glucose coupling and an alternating‑access mechanism typical of the SSF transporter family. This high‑affinity profile contrasts with SGLT2’s lower affinity and 1:1 coupling (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; Frontiers in Molecular Biosciences, 2025, https://doi.org/10.3389/fmolb.2025.1668400) (azizogli2023comparisonofsglt1 pages 3-5, kaijage2025molecularmechanismsand pages 2-3).
2) Tissue and cellular localization in rat
• Intestine: SGLT1 is localized to the brush‑border (apical) membrane of enterocytes, mediating dietary glucose/galactose absorption. Rat experiments directly demonstrate SGLT‑dependent uptake in intestinal sacs and β2‑AR‑driven acute regulation (Frontiers in Cell and Developmental Biology, 2023, https://doi.org/10.3389/fcell.2022.1041930) (paulussen2023theβ2adrenergicreceptor pages 11-14).
• Kidney: In rat and other mammals, SGLT1 is localized to the late proximal tubule (S3), reclaiming the final portion of filtered glucose after the bulk reabsorption by SGLT2 in S1/S2 (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143) (azizogli2023comparisonofsglt1 pages 3-5).
• Heart: SGLT1 is detected in cardiomyocytes and other cardiac cell types; preclinical/translational compilations report upregulation in pressure/volume overload and diabetic/ischemic cardiomyopathy (preclinical/translational review, 2024) (mroueh2024preclinicalandtranslationalb pages 84-88, mroueh2024preclinicalandtranslational pages 84-88, mroueh2024preclinicalandtranslationala pages 84-88).
3) Mechanism and domains (SSF family)
SGLT1 is an SSF family member whose Na+-coupled alternating‑access cycle enables secondary active transport. Comparative structural biology across SGLTs (including SGLT2 cryo‑EM with MAP17) provides mechanistic insights into Na+-binding, gating transitions, and inhibitor binding modes that, by homology, inform SGLT1 annotation (Frontiers in Molecular Biosciences, 2025, https://doi.org/10.3389/fmolb.2025.1668400) (kaijage2025molecularmechanismsand pages 2-3).
4) Regulation by diet/fasting, hormones/GPCRs, kinases, ischemia
• Luminal carbohydrate and diurnal control: Intestinal SGLT1 expression/activity is upregulated by luminal carbohydrate and exhibits segment‑dependent regulation; contemporary syntheses highlight proximal > distal expression and incretin coupling as adaptive responses (Rottenberger, 2024) (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70).
• β2‑AR/PKA signaling in rat intestine: β2‑adrenergic receptor at the apical membrane senses sugars and epinephrine, promoting PKA‑dependent SGLT1 translocation and enhanced uptake in rat enterocytes (Frontiers in Cell and Developmental Biology, 2023, https://doi.org/10.3389/fcell.2022.1041930) (paulussen2023theβ2adrenergicreceptor pages 11-14).
• PKC/PKA post‑translational modulation and cardiometabolic stresses: Reviews summarize PKA/PKC phosphorylation sites, leptin/insulin effects, and upregulation with pressure/volume overload or ischemic/diabetic cardiomyopathy; these compile mechanistic regulation relevant to SGLT1 in intestine and heart (preclinical/translational review, 2024) (mroueh2024preclinicalandtranslationalb pages 84-88, mroueh2024preclinicalandtranslational pages 84-88, mroueh2024preclinicalandtranslationala pages 84-88).
5) Roles in pathophysiology and compensatory changes
• Diarrhea: When intestinal SGLT1 is inhibited (e.g., dual SGLT1/2 inhibitors), carbohydrate malabsorption increases luminal osmotic load and water retention, leading to diarrhea; this mechanism is highlighted in transporter‑focused safety analyses (Pharmaceutics, 2024, https://doi.org/10.3390/pharmaceutics16040447) (kharve2024impactofdrugmediated pages 4-7).
• Renal compensation during SGLT2 inhibition: With SGLT2 blocked, glucose delivery distally increases and SGLT1 in late PT/S3 becomes proportionally more consequential, with downstream segmental adjustments (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; preclinical/translational review, 2024) (azizogli2023comparisonofsglt1 pages 3-5, mroueh2024preclinicalandtranslationalb pages 84-88).
6) Applications: SGLT1‑selective and dual inhibitors; selectivity and clinical findings
• Sotagliflozin (dual SGLT1/2) lowers postprandial and fasting glucose via intestinal and renal actions but has GI adverse effects consistent with intestinal SGLT1 inhibition. Contemporary comparisons and PBPK modeling rank sotagliflozin highest for SGLT1 inhibition among evaluated agents (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; Frontiers in Pharmacology, 2023, https://doi.org/10.3389/fphar.2023.1142003) (azizogli2023comparisonofsglt1 pages 3-5, kharve2024impactofdrugmediated pages 4-7).
• LX2761 (nonabsorbable SGLT1 inhibitor) is designed to be gut‑restricted to reduce postprandial glycemia with reduced systemic exposure (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; Pharmaceutics, 2024, https://doi.org/10.3390/pharmaceutics16040447) (azizogli2023comparisonofsglt1 pages 3-5, kharve2024impactofdrugmediated pages 4-7).
7) Quantitative parameters and data needs
• Stoichiometry and fractional renal contribution are well‑supported (2:1 Na+:glucose; ~3% SGLT1 renal reabsorption). Precise rat SGLT1 Km values were not directly resolved in the 2023–2024 sources identified here; the functional “high‑affinity” characterization is consistent across reviews and experimental contexts (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143) (azizogli2023comparisonofsglt1 pages 3-5).
Embedded summary table
| Aspect | Evidence / Quantitative value | Species / Preparation | Source (journal, year); URL/DOI |
|---|---|---:|---|
| Transport stoichiometry | 2 Na+ : 1 glucose; Na+-coupled alternating-access symport mechanism (mechanistic note: supports uphill glucose transport) (stoichiometry reported repeatedly) (azizogli2023comparisonofsglt1 pages 3-5, mroueh2024preclinicalandtranslationalb pages 84-88) | Mammalian / rat-characterized SGLT1 functional studies | Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Substrates & affinity | Transports D-glucose and D-galactose (high-affinity); does not transport fructose; described as high-affinity, low-capacity transporter (kaijage2025molecularmechanismsand pages 2-3, azizogli2023comparisonofsglt1 pages 3-5) | Human/rodent biochemical and transport assays | Frontiers in Molecular Biosciences, 2025; DOI: 10.3389/fmolb.2025.1668400 (kaijage2025molecularmechanismsand pages 2-3); Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Intestinal localization & β2-AR regulation | Apical brush-border of enterocytes; β2-adrenergic receptor (apical) stimulates SGLT1 translocation via PKA; rat everted-sac data: epinephrine (10 μM) increased luminal→tissue glucose accumulation 440 ±132 → 833 ±255 μM; effect blocked by β2 antagonist ICI 118,551 (10 μM); phlorizin (100 μM) or LX4211 (2 μM) inhibited >90% (paulussen2023theβ2adrenergicreceptor pages 11-14) | Rat, everted intestinal sac experiments (quantitative inhibitor/dose data) | Frontiers in Cell and Developmental Biology, Jan 2023; DOI: https://doi.org/10.3389/fcell.2022.1041930 (paulussen2023theβ2adrenergicreceptor pages 11-14) |
| Renal localization (nephron) | Localized to late proximal tubule (S3/late PT); contributes small fraction of renal reabsorption vs SGLT2 (reports: ~3%–<10% attributable to SGLT1 in kidney) (azizogli2023comparisonofsglt1 pages 3-5, mroueh2024preclinicalandtranslationalb pages 84-88) | Rodent/kidney segment expression & physiology analyses | Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Cardiac expression | Detected in cardiomyocytes, cardiac endothelial cells and other cardiac cell types; upregulated in pressure/volume overload and diabetic/ischemic cardiomyopathy (mroueh2024preclinicalandtranslationalb pages 84-88, rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70) | Preclinical rodent and translational studies | Mroueh (2024) (pre-clinical/translational review) (mroueh2024preclinicalandtranslationalb pages 84-88); Rottenberger (2024) (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70) |
| Pathophysiology — CDI / diarrhea | Drug or toxin-mediated loss of intestinal SGLT1 activity can produce carbohydrate accumulation and osmotic diarrhea; SGLT1 inhibition (e.g., sotagliflozin) linked to diarrhoeal adverse events in humans/rodents (kharve2024impactofdrugmediated pages 4-7) | Clinical observations and translational reviews; rodent models referenced | Pharmaceutics, 2024; DOI: https://doi.org/10.3390/pharmaceutics16040447 (kharve2024impactofdrugmediated pages 4-7) |
| Compensation with SGLT2 inhibition | Downstream nephron segments (including S3) show compensatory changes after SGLT2 inhibition; SGLT1-mediated uptake/behaviour in late PT becomes more relevant when SGLT2 inhibited (compensatory reabsorption shift) (mroueh2024preclinicalandtranslationalb pages 84-88, azizogli2023comparisonofsglt1 pages 3-5) | Rodent pharmacology/pathophysiology reviews and PBPK modeling context | Mroueh (2024) (mroueh2024preclinicalandtranslationalb pages 84-88); Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Incretin coupling & intestinal gradient | SGLT1 in enterocytes and enteroendocrine cells couples luminal glucose to GLP-1/GIP secretion; expression shows proximal→distal gradient (higher proximal/duodenum) and is luminal-carbohydrate responsive (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70, azizogli2023comparisonofsglt1 pages 3-5) | Mouse/rodent and translational intestine studies; pharmacologic knockouts/inhibitors | Rottenberger (2024) (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70); Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Water / urea permeation | SGLT1 can permit permeation of water and urea (functional uniport/permeation properties reported for SSF family members) (mroueh2024preclinicalandtranslationalb pages 84-88, rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70) | Biophysical/functional transporter studies (mammalian/rodent) | Mroueh (2024) (mroueh2024preclinicalandtranslationalb pages 84-88); Rottenberger (2024) (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70) |
| Structural / mechanistic features | Alternating-access Na+-coupled mechanism conserved across SSF family; family motifs noted (e.g., Pro–Pro motif in related SGLTs) and structural advances inform inhibitor binding and state transitions (kaijage2025molecularmechanismsand pages 2-3, azizogli2023comparisonofsglt1 pages 3-5) | Structural biology, modeling and comparative analyses (human/orthologs) | Frontiers in Molecular Biosciences, 2025; DOI: 10.3389/fmolb.2025.1668400 (kaijage2025molecularmechanismsand pages 2-3); Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Inhibitors & selectivity (clinical/translational) | Sotagliflozin — dual SGLT1/SGLT2 (potent SGLT1 inhibition; reported in vitro IC50 ≈ 0.036 μM for SGLT2 with notable SGLT1 activity and GI effects); LX2761 — nonabsorbable SGLT1-targeted agent; PBPK ranking: sotagliflozin > ertugliflozin/empagliflozin for SGLT1 inhibition in some models (kharve2024impactofdrugmediated pages 4-7, azizogli2023comparisonofsglt1 pages 3-5) | Clinical trials, PBPK and translational studies; mixed human/rodent data | Pharmaceutics, 2024; DOI: https://doi.org/10.3390/pharmaceutics16040447 (kharve2024impactofdrugmediated pages 4-7); Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Quantitative renal handling | Clinical/physiological estimates: ≈97% of filtered glucose reabsorbed via SGLT2 (early PT); ≈3% by SGLT1 (late PT/S3) in several analyses (azizogli2023comparisonofsglt1 pages 3-5) | Integrated renal physiology estimates (rodent→human translational summaries) | Advanced Therapeutics, 2023; DOI: 10.1002/adtp.202300143 (azizogli2023comparisonofsglt1 pages 3-5) |
| Fasting / feeding regulation (jejunal) | Jejunal/segmental SGLT1 regulation: fasting increases jejunal SGLT1 activity/expression vs fed state (segment- and diet-dependent regulation conserved in rodents); a conserved paradigm for luminal carbohydrate-regulated expression (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70) | Mouse/rodent Ussing-chamber and membrane fraction studies; inferred conservation to rat | Rottenberger (2024) (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70) |
Table: Compact, sourced summary table of functional, localization, regulatory and translational data for rat Slc5a1 (SGLT1, UniProt P53790), with primary citations to the gathered evidence for quick reference.
Mandatory verification (symbol, organism, family)
• Gene symbol Slc5a1 unambiguously matches the SGLT1 transporter in rat; the literature reviewed consistently refers to SGLT1’s intestinal/renal/cardiac expression and 2:1 Na+:glucose mechanism, matching UniProt P53790 and SSF family/domain annotations (Advanced Therapeutics, 2023, https://doi.org/10.1002/adtp.202300143; preclinical/translational review, 2024) (azizogli2023comparisonofsglt1 pages 3-5, mroueh2024preclinicalandtranslationalb pages 84-88, mroueh2024preclinicalandtranslational pages 84-88, mroueh2024preclinicalandtranslationala pages 84-88).
Limitations and open points
• Rat‑specific kinetic constants (Km) and fine‑grained nephron‑segment expression atlases were not located within the retrieved 2023–2024 sources; future inclusion of rat‑focused primary physiologic measurements would strengthen quantitative annotation. Nonetheless, the key qualitative and semi‑quantitative features (stoichiometry, localization, regulatory paradigms) are robustly supported here (azizogli2023comparisonofsglt1 pages 3-5, paulussen2023theβ2adrenergicreceptor pages 11-14).
References (URLs and dates)
• Paulussen F et al., 2023. Frontiers in Cell and Developmental Biology. The β2‑adrenergic receptor in the apical membrane of intestinal enterocytes senses sugars to stimulate glucose uptake from the gut. URL: https://doi.org/10.3389/fcell.2022.1041930 (published Jan 2023). (paulussen2023theβ2adrenergicreceptor pages 11-14)
• Azizogli A‑R et al., 2023. Advanced Therapeutics. Comparison of SGLT1, SGLT2, and Dual Inhibitor Biological Activity in Treating Type 2 Diabetes Mellitus. URL: https://doi.org/10.1002/adtp.202300143 (Sep 2023). (azizogli2023comparisonofsglt1 pages 3-5)
• Rottenberger OF, 2024. Mechanisms underlying monosaccharide stimulated incretin hormone secretion from the intestine. Thesis/review with current synthesis (2024). (rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70)
• Kharve K et al., 2024. Pharmaceutics. Impact of Drug‑Mediated Inhibition of Intestinal Transporters on Nutrient and Endogenous Substrate Disposition…an Afterthought? URL: https://doi.org/10.3390/pharmaceutics16040447 (Mar 2024). (kharve2024impactofdrugmediated pages 4-7)
• Mroueh A, 2024. Pre‑clinical and translational studies of SGLT1/2 in arteries and hearts (review, 2024). (mroueh2024preclinicalandtranslationalb pages 84-88, mroueh2024preclinicalandtranslational pages 84-88, mroueh2024preclinicalandtranslationala pages 84-88)
• Kaijage N, Kraszewski S, 2025. Frontiers in Molecular Biosciences. Molecular mechanisms and computational insights into human SGLTs: advancing toward selective SGLT1 inhibition. URL: https://doi.org/10.3389/fmolb.2025.1668400 (Oct 2025) — used for mechanistic family context. (kaijage2025molecularmechanismsand pages 2-3)
References
(azizogli2023comparisonofsglt1 pages 3-5): Abdul‐Rahman Azizogli, Michael R Vitti, Richa Mishra, Laura Osorno, Corey Heffernan, and Vivek A Kumar. Comparison of sglt1, sglt2, and dual inhibitor biological activity in treating type 2 diabetes mellitus. Advanced Therapeutics, Sep 2023. URL: https://doi.org/10.1002/adtp.202300143, doi:10.1002/adtp.202300143. This article has 17 citations and is from a peer-reviewed journal.
(mroueh2024preclinicalandtranslationalb pages 84-88): A Mroueh. Pre-clinical and translational studies of the expression and role of sodium glucose co-transporters sglt1 and sglt2 in arteries and hearts under physiological and …. Unknown journal, 2024.
(mroueh2024preclinicalandtranslational pages 84-88): A Mroueh. Pre-clinical and translational studies of the expression and role of sodium glucose co-transporters sglt1 and sglt2 in arteries and hearts under physiological and …. Unknown journal, 2024.
(paulussen2023theβ2adrenergicreceptor pages 11-14): Frederik Paulussen, Chetan P. Kulkarni, Frank Stolz, Eveline Lescrinier, Stijn De Graeve, Suzan Lambin, Arnaud Marchand, Patrick Chaltin, Peter In't Veld, Joseph Mebis, Jan Tavernier, Patrick Van Dijck, Walter Luyten, and Johan M. Thevelein. The β2-adrenergic receptor in the apical membrane of intestinal enterocytes senses sugars to stimulate glucose uptake from the gut. Frontiers in Cell and Developmental Biology, Jan 2023. URL: https://doi.org/10.3389/fcell.2022.1041930, doi:10.3389/fcell.2022.1041930. This article has 2 citations and is from a poor quality or predatory journal.
(rottenberger2024mechanismsunderlyingmonosaccharidea pages 66-70): OF Rottenberger. Mechanisms underlying monosaccharide stimulated incretin hormone secretion from the intestine. Unknown journal, 2024.
(kharve2024impactofdrugmediated pages 4-7): Kshitee Kharve, Andrew S. Engley, Mary F. Paine, and Jason A. Sprowl. Impact of drug-mediated inhibition of intestinal transporters on nutrient and endogenous substrate disposition…an afterthought? Pharmaceutics, 16:447, Mar 2024. URL: https://doi.org/10.3390/pharmaceutics16040447, doi:10.3390/pharmaceutics16040447. This article has 1 citations and is from a poor quality or predatory journal.
(kaijage2025molecularmechanismsand pages 2-3): Nadhiri Kaijage and Sebastian Kraszewski. Molecular mechanisms and computational insights into human sglts: advancing toward selective sglt1 inhibition. Frontiers in Molecular Biosciences, Oct 2025. URL: https://doi.org/10.3389/fmolb.2025.1668400, doi:10.3389/fmolb.2025.1668400. This article has 0 citations and is from a poor quality or predatory journal.
(mroueh2024preclinicalandtranslationala pages 84-88): A Mroueh. Pre-clinical and translational studies of the expression and role of sodium glucose co-transporters sglt1 and sglt2 in arteries and hearts under physiological and …. Unknown journal, 2024.
Exported on March 22, 2026 at 01:01 AM
Organism: Rattus norvegicus
Sequence:
MDSSTLSPAVTATDAPIQSYERIRNAADISVIVIYFVVVMAVGLWAMFSTNRGTVGGFFLAGRSMVWWPIGASLFASNIGSGHFVGLAGTGAAAGIAMGGFEWNALVFVVVLGWLFVPIYIKAGVVTMPEYLRKRFGGKRIQIYLSVLSLLLYIFTKISADIFSGAIFINLALGLDIYLAIFILLAITALYTITGGLAAVIYTDTLQTAIMLVGSFILTGFAFREVGGYEAFMDKYMKAIPTLVSDGNITVKEECYTPRADSFHIFRDPITGDMPWPGLIFGLSILALWYWCTDQVIVQRCLSAKNMSHVKAGCTLCGYLKLLPMFLMVMPGMISRILYTDKIACVLPSECKKYCGTPVGCTNIAYPTLVVELMPNGLRGLMLSVMMASLMSSLTSIFNSASTLFTMDIYTKIRKGASEKELMIAGRLFILVLIGISIAWVPIVQSAQSGQLFDYIQSITSYLGPPIAAVFLLAIFCKRVNEPGAFWGLILGFLIGISRMITEFAYGTGSCMEPSNCPKIICGVHYLYFAIILFAISVVTVLVISLLTKPIPDVHLYRLCWSLRNSTEERIDLDAGEEEPVEEDPKDTIEIDAEAPQKEKGCFRKAYDLFCGLDQDKGPKMTKEEEEAMKLKMTDTSEKPLWRTVVNINGIILLAVAVFCHAYFA
I begin with the InterPro architecture. The core of the protein is defined by IPR001734 (Sodium/solute symporter family) spanning residues 25–506, which establishes a canonical sodium-coupled symporter scaffold. This scaffold is reinforced and generalized by IPR038377 (Sodium/glucose symporter superfamily) extending from residues 46–570, indicating an overall fold that coordinates Na+ with neutral or charged solutes through a multi-pass membrane topology. Embedded within this core, IPR018212 (Sodium/solute symporter, conserved site) from residues 174–494 marks a conserved functional region that typically harbors the Na+-coordination motifs and gating elements that drive alternating-access transport. The ordered layout—family-defining core (25–506), superfamily envelope (46–570), and a conserved catalytic site (174–494)—causally specifies a Na+-coupled transporter mechanism rather than a channel or ATP-driven pump.
This architecture dictates the molecular function: a secondary-active transporter that uses the inwardly directed Na+ electrochemical gradient to cotransport small solutes—here, neutral organic anions such as steroid sulfates and other circulating metabolites—across the membrane. That mechanism corresponds to GO:0015075 (molecular function) as the formal label for transport activity in this framework. The conserved-site signature and family membership causally support a tightly coupled, energy-harvesting transport cycle rather than facilitated diffusion.
From this function, I infer the biological process. Sodium-driven uptake of steroid sulfates and other endogenous anions integrates into epithelial and entoraceous solute handling, contributing to systemic solute balance and hormone precursor routing. This situates the protein squarely in transport-centered physiology, consistent with GO:0051234 (biological process). By harnessing Na+ gradients, the transporter supports epithelial absorption and transcellular flux pathways that maintain solute homeostasis.
Cellular location follows directly from the fold and mechanism. The sodium/solute symporter superfamily comprises multi-pass membrane proteins that embed stably in lipid bilayers; the long internal architecture and conserved transmembrane region predict a polytopic topology. This supports a membrane-resident role and matches a multi-pass membrane protein assignment. In epithelial contexts, such transporters typically populate apical or basolateral membranes to interface with luminal or interstitial solute pools; thus I infer localization as an integral membrane component.
Mechanistically, the transporter likely operates via an alternating-access cycle: Na+ binding to conserved sites stabilizes an outward-open state that captures steroid sulfates or other anions; cooperative binding triggers a conformational switch to inward-open, releasing both Na+ and substrate into the cytosol. This cycle predicts interaction partners that sustain its function. I hypothesize transient complexes with Na+-handling and trafficking machinery that maintain and regulate Na+-coupled uptake: apical Na+/K+-ATPase activity sets the driving force; PDZ-domain scaffolds and endocytic adaptors likely position and recycle the transporter; cytoskeletal linkers may stabilize membrane microdomains. Together, these interactions would tune surface abundance and transport capacity to match solute availability and physiological demand.
A multi-pass membrane transporter in rat that harnesses the inward sodium gradient to cotransport steroid sulfates and other circulating metabolites across cellular membranes. Its transmembrane architecture supports an alternating-access mechanism that couples Na+ binding to solute uptake, thereby contributing to epithelial and entoraceous solute handling and systemic homeostasis. The protein resides as an integral membrane component and likely operates at specialized membrane domains where sodium-driven transport is energetically favored.
Acts as a sodium-dependent anion transporter, able to transport steroid sulfates and several other endogenous compounds such as myo-inositol, 3,4-methylenedioxymethamphetamine (摇头娃娃) and D-methamphetamine.
IPR001734, family) — residues 25-506IPR038377, homologous_superfamily) — residues 46-570IPR018212, conserved_site) — residues 174-494Molecular Function: molecular_function (GO:0003674), transporter activity (GO:0005215), transmembrane transporter activity (GO:0022857), salt transmembrane transporter activity (GO:1901702), GO:0005215 (GO:0015075), inorganic molecular entity transmembrane transporter activity (GO:0015318), carbohydrate transmembrane transporter activity (GO:0015144), active transmembrane transporter activity (GO:0022804), inorganic cation transmembrane transporter activity (GO:0022890), carbohydrate:monoatomic cation symporter activity (GO:0005402), active monoatomic ion transmembrane transporter activity (GO:0022853), sugar transmembrane transporter activity (GO:0051119), monoatomic cation transmembrane transporter activity (GO:0008324), sodium ion transmembrane transporter activity (GO:0015081), secondary active transmembrane transporter activity (GO:0015291), symporter activity (GO:0015293), monosaccharide transmembrane transporter activity (GO:0015145), solute:monoatomic cation symporter activity (GO:0015294), metal ion transmembrane transporter activity (GO:0046873), solute:sodium symporter activity (GO:0015370), hexose transmembrane transporter activity (GO:0015149), glucose transmembrane transporter activity (GO:0005355)
Biological Process: biological_process (GO:0008150), cellular process (GO:0009987), localization (GO:0051179), multicellular organismal process (GO:0032501), GO:0009987 (GO:0051234), digestion (GO:0007586), transmembrane transport (GO:0055085), system process (GO:0003008), digestive system process (GO:0022600), carbohydrate transmembrane transport (GO:0034219), transport (GO:0006810), intestinal absorption (GO:0050892), monosaccharide transmembrane transport (GO:0015749), organic substance transport (GO:0071702), hexose transmembrane transport (GO:0008645), carbohydrate transport (GO:0008643), glucose transmembrane transport (GO:1904659)
Cellular Component: cellular_component (GO:0005575), cellular anatomical entity (GO:0110165), intracellular anatomical structure (GO:0005622), organelle (GO:0043226), GO:0043226 (GO:0045178), apical part of cell (GO:0045177), cell projection (GO:0042995), membrane (GO:0016020), cell junction (GO:0030054), cell periphery (GO:0071944), cluster of actin-based cell projections (GO:0098862), basal plasma membrane (GO:0009925), plasma membrane region (GO:0098590), plasma membrane bounded cell projection (GO:0120025), intracellular organelle (GO:0043229), brush border (GO:0005903), anchoring junction (GO:0070161), plasma membrane (GO:0005886), apical plasma membrane (GO:0016324), brush border membrane (GO:0031526), cell projection membrane (GO:0031253), basolateral plasma membrane (GO:0016323), cell-cell junction (GO:0005911)
Generated by BioReason
Source: Slc5a1-bioreason-rl-predictions.md
The functional summary states:
A multi-pass membrane transporter in rat that harnesses the inward sodium gradient to cotransport steroid sulfates and other circulating metabolites across cellular membranes. Its transmembrane architecture supports an alternating-access mechanism that couples Na+ binding to solute uptake, thereby contributing to epithelial and entoraceous solute handling and systemic homeostasis.
This contains a fundamental error. Slc5a1 (SGLT1) is the sodium/glucose cotransporter 1, a high-affinity Na+-coupled symporter that actively transports D-glucose and D-galactose with 2:1 Na+:glucose stoichiometry. The curated review clearly identifies glucose transmembrane transporter activity (GO:0005355), glucose transmembrane transport (GO:1904659), monosaccharide transmembrane transport (GO:0015749), intestinal absorption (GO:0050892), and apical plasma membrane localization (GO:0016324).
BioReason incorrectly identifies the substrate as "steroid sulfates and other circulating metabolites." This error appears to stem from the UniProt summary for this entry, which mentions sodium-dependent anion transport of steroid sulfates. However, the UniProt entry for the rat P53790 protein -- which is indeed SGLT1 (Slc5a1) -- apparently describes a broader sodium/solute symporter capacity that is misleading. The core, best-characterized function of SGLT1 is glucose/galactose transport, not steroid sulfate transport. The BioReason system appears to have been misled by the UniProt summary text rather than correctly prioritizing the glucose transport function that is overwhelmingly supported by the curated annotations.
Furthermore, the term "entoraceous" is not a standard biological term. The correct context is intestinal epithelial cells (enterocytes) in the brush border membrane for dietary sugar absorption, and proximal tubule cells in the kidney for glucose reabsorption.
The curated review has extensive annotations including solute:sodium symporter activity (GO:0015370), carbohydrate:cation symporter activity (GO:0005402), apical plasma membrane (GO:0016324), brush border membrane (GO:0031526), and specific localization in intestine and kidney -- none of which are accurately captured.
Comparison with interpro2go:
The interpro2go annotations for Slc5a1 include membrane (GO:0016020), transmembrane transporter activity (GO:0022857), and transmembrane transport (GO:0055085). BioReason recapitulates the membrane localization and transporter activity at this general level. However, BioReason's predicted GO terms (shown at the bottom of the file) actually include glucose transmembrane transporter activity (GO:0005355) and glucose transmembrane transport (GO:1904659), suggesting the model's GO term predictions are more accurate than its functional summary narrative. The functional summary diverges from the model's own GO predictions by emphasizing steroid sulfates over glucose.
The trace correctly identifies the sodium/solute symporter family (IPR001734) and sodium/glucose symporter superfamily (IPR038377) but then inexplicably focuses on steroid sulfates rather than glucose as the primary substrate. This is a clear case where the domain names ("sodium/glucose symporter") should have guided the narrative toward glucose transport. The alternating-access mechanism description is generically correct but applied to the wrong substrate. The mention of "epithelial and entoraceous solute handling" gestures toward the correct tissue context but with wrong substrate specificity.
id: P53790
gene_symbol: Slc5a1
aliases:
- Sglt1
- SGLT1
- Na+/glucose cotransporter 1
- Sodium/glucose cotransporter 1
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:10116
label: Rattus norvegicus
description: >-
Sodium/glucose cotransporter 1 (SGLT1) is a high-affinity Na+-coupled symporter
that actively transports D-glucose and D-galactose across the plasma membrane with
2:1 Na+:glucose stoichiometry. SGLT1 is the primary transporter for dietary hexose
absorption across the apical brush-border membrane of enterocytes in the small intestine.
In kidney, it functions in the S3 segment of proximal tubules for glucose reabsorption,
handling approximately 3% of filtered glucose. Additionally serves as a water channel
enabling passive water transport. Located at the blood-brain barrier in endothelial
cells.
existing_annotations:
# ============================================================================
# CELLULAR COMPONENT ANNOTATIONS
# ============================================================================
# --- Apical plasma membrane (4 annotations with different evidence) ---
- term:
id: GO:0016324
label: apical plasma membrane
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation based on phylogenetic inference. SGLT1 apical localization
is well-established
across mammals. Direct experimental evidence in rat shows SGLT1 at apical
membrane in
MDCK cells (PMID:11831390), blood-brain barrier endothelial cells (PMID:14986005),
and kidney proximal tubule S3 segments (PMID:16204409).
action: ACCEPT
reason: >-
Core localization for SGLT1 function. Phylogenetic inference is well-supported
by multiple
direct experimental studies in rat demonstrating apical membrane localization
in intestinal
epithelium, renal proximal tubules, and brain endothelial cells. The N-terminal
domain
determines apical targeting (PMID:11831390).
supported_by:
- reference_id: PMID:11831390
supporting_text: "The products of N-terminal deletion clones up to the 19th
amino acid were localized at the apical plasma membrane"
- reference_id: PMID:14986005
supporting_text: "Immunostaining suggested that SGLT1 is located in the
luminal membrane of the endothelial cells"
- reference_id: file:rat/Slc5a1/Slc5a1-deep-research-falcon.md
supporting_text: 'model: Edison Scientific Literature'
- term:
id: GO:0016324
label: apical plasma membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
review:
summary: >-
IEA annotation based on UniProtKB/Swiss-Prot subcellular location mapping.
Redundant with IBA and IDA annotations for same term.
action: ACCEPT
reason: >-
While redundant with IBA annotation, this IEA represents valid automated inference
from UniProt subcellular location annotation. Duplicates are acceptable in
GO as they
represent independent evidence paths. Core localization is correct.
- term:
id: GO:0016324
label: apical plasma membrane
evidence_type: IDA
original_reference_id: PMID:14986005
review:
summary: >-
Direct experimental evidence from immunohistochemistry in rat brain capillaries
showing
SGLT1 in luminal (apical) membrane of blood-brain barrier endothelial cells.
action: ACCEPT
reason: >-
High-quality experimental evidence demonstrating apical localization in brain
endothelial
cells. The study showed immunoreactivity in intracerebral capillaries with
staining
in the luminal membrane.
supported_by:
- reference_id: PMID:14986005
supporting_text: "Immunostaining suggested that SGLT1 is located in the
luminal membrane of the endothelial cells and in intracellular vesicles"
- term:
id: GO:0016324
label: apical plasma membrane
evidence_type: IDA
original_reference_id: PMID:11831390
review:
summary: >-
Direct experimental evidence from MDCK cell localization studies showing rat
SGLT1
localizes to apical plasma membrane. N-terminal deletion analysis identified
apical
targeting signals.
action: ACCEPT
reason: >-
High-quality experimental evidence. Study used rat SGLT1 expressed in MDCK
cells and
demonstrated apical localization, with identification of the N-terminal targeting
domain.
supported_by:
- reference_id: PMID:11831390
supporting_text: "SGLT1, an isoform of Na+-dependent glucose cotransporters,
is localized at the apical plasma membrane in the epithelial cells of
the small intestine and the kidney"
- term:
id: GO:0016324
label: apical plasma membrane
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation transferred from other mammalian species by RGD. Redundant
with
multiple direct experimental annotations (IDA) for rat SGLT1.
action: ACCEPT
reason: >-
Valid ortholog transfer that is consistent with direct rat experimental evidence.
Duplicates are acceptable as independent evidence paths.
# --- Plasma membrane (2 annotations) ---
- term:
id: GO:0005886
label: plasma membrane
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for plasma membrane localization. This is a parent term of
apical plasma membrane (GO:0016324) which is the more specific correct localization.
action: KEEP_AS_NON_CORE
reason: >-
While technically correct, this is less specific than apical plasma membrane.
The more specific term GO:0016324 better captures SGLT1's polarized localization.
Acceptable to retain as it captures the broader membrane context.
- term:
id: GO:0005886
label: plasma membrane
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation transferred from mammalian orthologs. Less specific than apical
plasma membrane annotations.
action: KEEP_AS_NON_CORE
reason: >-
Valid but less specific than apical plasma membrane. The more specific term
GO:0016324 is preferred for capturing SGLT1's polarized epithelial localization.
# --- Brush border membrane (2 IDA annotations) ---
- term:
id: GO:0031526
label: brush border membrane
evidence_type: IDA
original_reference_id: PMID:14986005
review:
summary: >-
Brush border membrane localization is well supported for intestinal SGLT1,
but PMID:14986005 itself focuses on brain capillary localization. Accept the
term based on direct intestinal apical membrane evidence from other sources.
action: ACCEPT
reason: >-
The brush border membrane term is appropriate for intestinal SGLT1, even
though PMID:14986005 is likely a misassigned reference. Experimental data
from intestinal apical membrane preparations support this localization.
supported_by:
- reference_id: PMID:17272350
supporting_text: Western blotting showed that in each case there was a
significant decrease in apical GLUT2 level, but no change in SGLT1 level.
- term:
id: GO:0031526
label: brush border membrane
evidence_type: IDA
original_reference_id: PMID:17272350
review:
summary: >-
Direct experimental evidence showing SGLT1 at intestinal brush border membrane
in
rat jejunum. Western blotting confirmed SGLT1 presence in apical membrane
preparations.
action: ACCEPT
reason: >-
High-quality experimental evidence demonstrating SGLT1 at brush border membrane
of rat intestinal epithelium. This is a core localization for intestinal glucose
absorption.
supported_by:
- reference_id: PMID:17272350
supporting_text: "Western blotting showed that in each case there was a
significant decrease in apical GLUT2 level, but no change in SGLT1 level"
# --- Brush border (ISO) ---
- term:
id: GO:0005903
label: brush border
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation for brush border localization. Brush border (GO:0005903) is
the
parent of brush border membrane (GO:0031526). The more specific membrane term
is more accurate for a transmembrane transporter.
action: MODIFY
reason: >-
For a transmembrane transporter, the more specific term brush border membrane
(GO:0031526) is more appropriate than the general brush border term.
proposed_replacement_terms:
- id: GO:0031526
label: brush border membrane
# --- Membrane (IEA) ---
- term:
id: GO:0016020
label: membrane
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
Very general IEA annotation based on InterPro record mapping. SGLT1 has many
more specific membrane annotations (apical plasma membrane, brush border membrane).
action: MARK_AS_OVER_ANNOTATED
reason: >-
This is too general to be informative. SGLT1 has specific annotations to apical
plasma membrane and brush border membrane that are much more informative.
While technically correct, this adds no useful information.
# --- Organelle (IDA) ---
- term:
id: GO:0043226
label: organelle
evidence_type: IDA
original_reference_id: PMID:14986005
review:
summary: >-
The paper mentions intracellular vesicles containing SGLT1 in brain endothelial
cells. However, 'organelle' is extremely vague and should be more specific.
action: MODIFY
reason: >-
The paper specifically mentions intracellular vesicles, not generic organelles.
A more specific term would be appropriate if we want to capture this localization.
proposed_replacement_terms:
- id: GO:0031410
label: cytoplasmic vesicle
supported_by:
- reference_id: PMID:14986005
supporting_text: "Immunostaining suggested that SGLT1 is located in the
luminal membrane of the endothelial cells and in intracellular vesicles"
# --- Basolateral plasma membrane (TAS) ---
- term:
id: GO:0016323
label: basolateral plasma membrane
evidence_type: TAS
original_reference_id: PMID:14986005
review:
summary: >-
Questionable annotation. PMID:14986005 specifically shows SGLT1 in the LUMINAL
(apical) membrane of brain endothelial cells, not basolateral. This appears
to
be an error in annotation.
action: REMOVE
reason: >-
The cited paper explicitly states SGLT1 is in the luminal membrane, which
is the
apical/blood-facing side of brain capillary endothelium, not basolateral.
SGLT1
is canonically an apical transporter; basolateral glucose exit is mediated
by GLUT2.
supported_by:
- reference_id: PMID:14986005
supporting_text: "Immunostaining suggested that SGLT1 is located in the
luminal membrane of the endothelial cells"
# --- Cell-cell junction (IDA) ---
- term:
id: GO:0005911
label: cell-cell junction
evidence_type: IDA
original_reference_id: PMID:17090404
review:
summary: >-
Direct experimental evidence showing SGLT1 clusters at cell-cell junctions
in
arterial endothelium. High-density clusters found in proximity to cell-to-cell
junctions.
action: KEEP_AS_NON_CORE
reason: >-
Valid experimental finding in endothelial cells showing SGLT1 clustering near
cell-cell junctions. This represents a secondary localization pattern in vascular
endothelium, not the primary physiological localization in intestine/kidney.
supported_by:
- reference_id: PMID:17090404
supporting_text: "Clusters of the glucose transporter isoforms were found
at a high density in proximity to the cell-to-cell junctions"
# --- Early endosome (ISO) ---
- term:
id: GO:0005769
label: early endosome
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation from mammalian orthologs. SGLT1 trafficking through endosomal
compartments is plausible for membrane protein recycling.
action: KEEP_AS_NON_CORE
reason: >-
Likely reflects trafficking/recycling rather than steady-state functional
localization. Not a core localization but may be valid for protein turnover.
# --- Perinuclear region of cytoplasm (ISO) ---
- term:
id: GO:0048471
label: perinuclear region of cytoplasm
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation from orthologs. May reflect biosynthetic pathway localization
(ER/Golgi) rather than functional localization.
action: KEEP_AS_NON_CORE
reason: >-
Likely reflects biosynthetic pathway (ER/Golgi in perinuclear region) rather
than functional localization. Not a core localization for SGLT1 function.
# ============================================================================
# MOLECULAR FUNCTION ANNOTATIONS
# ============================================================================
# --- D-glucose:sodium symporter activity (4 annotations) ---
- term:
id: GO:0005412
label: D-glucose:sodium symporter activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
Core molecular function of SGLT1 - IBA based on phylogenetic inference.
This is the defining activity of the SGLT1 transporter family.
action: ACCEPT
reason: >-
This is THE core molecular function of SGLT1. The transporter catalyzes
2 Na+ : 1 D-glucose cotransport as established across all species.
UniProt confirms this catalytic activity with Rhea reaction annotation.
supported_by:
- reference_id: PMID:15829715
supporting_text: "the renal brush-border membrane Na+/glucose co-transporter-1
(SGLT1) is a molecular target for Cd2+ toxicity"
- term:
id: GO:0005412
label: D-glucose:sodium symporter activity
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation from mammalian orthologs. Consistent with direct rat evidence.
action: ACCEPT
reason: >-
Core molecular function, well-supported by direct rat experimental evidence
and consistent phylogenetic conservation.
- term:
id: GO:0005412
label: D-glucose:sodium symporter activity
evidence_type: IDA
original_reference_id: PMID:15829715
review:
summary: >-
Direct experimental evidence showing rat SGLT1 Na+/glucose cotransport activity.
Study used methyl-D-glucopyranoside uptake assays in SGLT1-expressing cells.
action: ACCEPT
reason: >-
High-quality direct experimental evidence demonstrating the core molecular
function in rat SGLT1.
supported_by:
- reference_id: PMID:15829715
supporting_text: "Cd2+ acted as a noncompetitive, partial inhibitor of methyl-D-glucopyranoside
uptake in vesicles from COS-7 cells transiently expressing SGLT1"
- term:
id: GO:0005412
label: D-glucose:sodium symporter activity
evidence_type: TAS
original_reference_id: PMID:11831390
review:
summary: >-
TAS annotation from paper on SGLT1 apical localization. Paper discusses SGLT1
as glucose transporter but main focus is localization not transport activity.
action: ACCEPT
reason: >-
The paper refers to SGLT1's known function as Na+-dependent glucose cotransporter.
While the experimental focus is localization, the stated function is accurate.
supported_by:
- reference_id: PMID:11831390
supporting_text: "SGLT1, an isoform of Na+-dependent glucose cotransporters,
is localized at the apical plasma membrane"
# --- Galactose:sodium symporter activity (2 annotations) ---
- term:
id: GO:0015371
label: galactose:sodium symporter activity
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation for galactose transport. SGLT1 transports both D-glucose and
D-galactose with similar affinity - this is well-established in the literature.
action: ACCEPT
reason: >-
Core molecular function. SGLT1 transports D-galactose as well as D-glucose,
both with high affinity. UniProt catalytic activity annotation confirms this.
PMID:16204409 used galactose uptake to measure SGLT1 activity.
supported_by:
- reference_id: PMID:16204409
supporting_text: "The phlorizin-sensitive uptake of d-[(3)H]galactose in
BBM vesicles"
- term:
id: GO:0015371
label: galactose:sodium symporter activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation based on sequence similarity. Consistent with ISO annotation
and UniProt functional annotation.
action: ACCEPT
reason: >-
Core molecular function. Galactose transport by SGLT1 is well-established
and conserved across species.
# --- Water transmembrane transporter activity (2 annotations) ---
- term:
id: GO:0005372
label: water transmembrane transporter activity
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for water transport. SGLT1 functions as a water channel with
high water conductivity comparable to aquaporins, enabling passive water transport.
action: ACCEPT
reason: >-
Core molecular function. UniProt describes SGLT1 as having high water conductivity
comparable to aquaporins, enabling passive water transport in response to
osmotic
gradients created during sugar/Na+ uptake.
- term:
id: GO:0005372
label: water transmembrane transporter activity
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation from orthologs for water transport activity.
action: ACCEPT
reason: >-
Core molecular function. Water transport by SGLT1 is well-documented and
important for transepithelial water permeability in intestine.
# --- D-glucose transmembrane transporter activity (ISO) ---
- term:
id: GO:0055056
label: D-glucose transmembrane transporter activity
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation for general glucose transporter activity. This is less specific
than D-glucose:sodium symporter activity which captures the coupling mechanism.
action: KEEP_AS_NON_CORE
reason: >-
While correct, this is less informative than D-glucose:sodium symporter activity
(GO:0005412) which specifies the sodium-coupling mechanism that defines SGLT1.
# --- Alpha-glucoside transmembrane transporter activity (ISO) ---
- term:
id: GO:0015151
label: alpha-glucoside transmembrane transporter activity
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation for alpha-glucoside transport. SGLT1 transports glucose (an
alpha-glucoside in its cyclic form), but this term is typically used for
disaccharide transport (e.g., maltose, sucrose). May be an over-annotation.
action: MARK_AS_OVER_ANNOTATED
reason: >-
SGLT1 transports monosaccharides (glucose, galactose), not alpha-glucosides
like maltose or sucrose. The more accurate term is D-glucose:sodium symporter
activity. This term implies transport of glycosides/disaccharides which is
not the primary function.
# --- Symporter activity (IEA) ---
- term:
id: GO:0015293
label: symporter activity
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
IEA annotation from UniProtKB keyword mapping. Very general term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Too general. The specific term D-glucose:sodium symporter activity (GO:0005412)
is much more informative and captures the actual substrate specificity.
# --- Transmembrane transporter activity (IEA) ---
- term:
id: GO:0022857
label: transmembrane transporter activity
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
Very general IEA annotation from InterPro mapping.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Far too general to be informative. Specific molecular function annotations
(D-glucose:sodium symporter activity) provide the relevant information.
# --- Monoatomic cation transmembrane transporter activity (IEA) ---
- term:
id: GO:0008324
label: monoatomic cation transmembrane transporter activity
evidence_type: IEA
original_reference_id: GO_REF:0000117
review:
summary: >-
IEA from ARBA machine learning. SGLT1 uses Na+ gradient to drive glucose transport
but is not primarily a cation transporter - it is a sugar transporter.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Misleading annotation. While SGLT1 translocates Na+ ions, it is primarily
a
sugar transporter that uses the Na+ gradient as driving force. The sodium
transport is coupled to/incidental to the primary glucose transport function.
# ============================================================================
# BIOLOGICAL PROCESS ANNOTATIONS
# ============================================================================
# --- Intestinal D-glucose absorption (3 annotations) ---
- term:
id: GO:0001951
label: intestinal D-glucose absorption
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation for intestinal glucose absorption - THE core biological process
for SGLT1 in the gut.
action: ACCEPT
reason: >-
Core biological process. SGLT1 is the primary transporter for dietary glucose
absorption across enterocyte brush border membrane.
supported_by:
- reference_id: PMID:17272350
supporting_text: "We have proposed a model of intestinal glucose absorption
in which transport by SGLT1 induces rapid insertion and activation of
GLUT2"
- term:
id: GO:0001951
label: intestinal D-glucose absorption
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation from orthologs. Consistent with direct rat evidence.
action: ACCEPT
reason: >-
Core biological process, well-supported by rat experimental evidence.
- term:
id: GO:0001951
label: intestinal D-glucose absorption
evidence_type: TAS
original_reference_id: PMID:15829715
review:
summary: >-
TAS annotation. The paper's main focus is cadmium inhibition of SGLT1, but
mentions intestinal glucose absorption as established SGLT1 function.
action: ACCEPT
reason: >-
Core biological process. While paper focuses on cadmium effects, it references
SGLT1's role in intestinal glucose absorption.
# --- Renal D-glucose absorption (3 annotations) ---
supported_by:
- reference_id: PMID:15829715
supporting_text: 2005 Apr 13. The endogenous CXXC motif governs the
cadmium sensitivity of the renal Na+/glucose co-transporter.
- term:
id: GO:0035623
label: renal D-glucose absorption
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for renal glucose reabsorption. SGLT1 handles glucose reabsorption
in S3 segment of proximal tubule (minor fraction, ~3% of total).
action: ACCEPT
reason: >-
Core biological process. PMID:16204409 directly demonstrates SGLT1 in rat
kidney
S3 proximal tubule segments with functional glucose transport activity.
supported_by:
- reference_id: PMID:16204409
supporting_text: "SGLT1 (SLC5A1) mediates a part of glucose and galactose
reabsorption in the mammalian proximal tubule"
- reference_id: PMID:16204409
supporting_text: "the expression of SGLT1 is represented by a 75-kDa protein
localized largely in the PT S3 segments"
- term:
id: GO:0035623
label: renal D-glucose absorption
evidence_type: ISS
original_reference_id: GO_REF:0000024
review:
summary: >-
ISS annotation from sequence similarity. Consistent with direct rat evidence.
action: ACCEPT
reason: >-
Core biological process, well-supported by direct rat experimental evidence.
- term:
id: GO:0035623
label: renal D-glucose absorption
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation from orthologs. Consistent with IBA and direct rat evidence.
action: ACCEPT
reason: >-
Core biological process with strong experimental support in rat.
# --- D-glucose import across plasma membrane (2 annotations) ---
- term:
id: GO:0098708
label: D-glucose import across plasma membrane
evidence_type: IBA
original_reference_id: GO_REF:0000033
review:
summary: >-
IBA annotation for glucose import. Accurate description of SGLT1's transport
direction (import into cell).
action: ACCEPT
reason: >-
Core biological process. SGLT1 imports glucose from lumen into epithelial
cells.
This is a fundamental aspect of its transport function.
- term:
id: GO:0098708
label: D-glucose import across plasma membrane
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation from orthologs. Consistent with IBA annotation.
action: ACCEPT
reason: >-
Core biological process describing the import direction of SGLT1-mediated
glucose transport.
# --- D-glucose transmembrane transport (2 annotations) ---
- term:
id: GO:1904659
label: D-glucose transmembrane transport
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation for glucose transmembrane transport.
action: ACCEPT
reason: >-
Core biological process. This is the primary transport function of SGLT1.
- term:
id: GO:1904659
label: D-glucose transmembrane transport
evidence_type: TAS
original_reference_id: PMID:11831390
review:
summary: >-
TAS annotation. Paper focuses on localization but references SGLT1's glucose
transport function.
action: ACCEPT
reason: >-
Core biological process. While paper's experimental focus is localization,
SGLT1's glucose transport function is accurately referenced.
supported_by:
- reference_id: PMID:11831390
supporting_text: "SGLT1 glucose transporter...plays a pivotal role in the
absorption and reabsorption of sugars"
# --- Galactose transmembrane transport (IEA) ---
- term:
id: GO:0015757
label: galactose transmembrane transport
evidence_type: IEA
original_reference_id: GO_REF:0000108
review:
summary: >-
IEA annotation based on logical inference. SGLT1 transports galactose with
similar affinity to glucose - this is experimentally demonstrated in rat.
action: ACCEPT
reason: >-
Core biological process. Galactose transport by SGLT1 is well-established.
PMID:16204409 used galactose uptake assays to measure rat SGLT1 activity.
supported_by:
- reference_id: PMID:16204409
supporting_text: "SGLT1 (SLC5A1) mediates a part of glucose and galactose
reabsorption in the mammalian proximal tubule"
# --- Intestinal absorption (2 annotations) ---
- term:
id: GO:0050892
label: intestinal absorption
evidence_type: TAS
original_reference_id: PMID:16204409
review:
summary: >-
TAS annotation. The paper primarily focuses on kidney, though it mentions
intestinal absorption as SGLT1 function.
action: ACCEPT
reason: >-
Core biological process. SGLT1's role in intestinal absorption is well-established.
supported_by:
- reference_id: PMID:16204409
supporting_text: "SGLT1 (SLC5A1) mediates a part of glucose and galactose
reabsorption in the mammalian proximal tubule"
- term:
id: GO:0050892
label: intestinal absorption
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation from orthologs. Consistent with known SGLT1 function.
action: ACCEPT
reason: >-
Core biological process for SGLT1 in the gut.
# --- Transepithelial water transport (ISO) ---
- term:
id: GO:0035377
label: transepithelial water transport
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation for water transport function. SGLT1 acts as a water channel
with high conductivity comparable to aquaporins.
action: ACCEPT
reason: >-
Core biological process. SGLT1's water transport activity is important for
intestinal water absorption coupled to glucose/Na+ uptake.
# --- Sodium ion import across plasma membrane (ISO) ---
- term:
id: GO:0098719
label: sodium ion import across plasma membrane
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation for sodium import. SGLT1 couples 2 Na+ import per glucose.
action: KEEP_AS_NON_CORE
reason: >-
While technically accurate (SGLT1 imports 2 Na+ per glucose), sodium transport
is secondary to the primary function of glucose transport. The Na+ gradient
drives glucose uptake rather than being the primary transported substrate.
# --- Sodium ion transport (IEA) ---
- term:
id: GO:0006814
label: sodium ion transport
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
IEA annotation from UniProtKB keyword mapping.
action: KEEP_AS_NON_CORE
reason: >-
While Na+ is cotransported with glucose, this annotation may give the misleading
impression that SGLT1 is primarily a sodium transporter. The primary function
is glucose transport using the Na+ gradient.
# --- Monoatomic ion transport (IEA) ---
- term:
id: GO:0006811
label: monoatomic ion transport
evidence_type: IEA
original_reference_id: GO_REF:0000043
review:
summary: >-
Very general IEA annotation for ion transport.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Too general and misleading. SGLT1 is a sugar transporter that cotransports
sodium, not primarily an ion transporter.
# --- Transmembrane transport (IEA) ---
- term:
id: GO:0055085
label: transmembrane transport
evidence_type: IEA
original_reference_id: GO_REF:0000002
review:
summary: >-
Very general IEA annotation from InterPro mapping.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Far too general to be informative. Specific process annotations provide the
relevant information about SGLT1 function.
# --- Transport across blood-brain barrier (ISO) ---
- term:
id: GO:0150104
label: transport across blood-brain barrier
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation for BBB transport. Rat experimental evidence shows SGLT1
in brain capillary endothelium with upregulation after ischemia.
action: KEEP_AS_NON_CORE
reason: >-
Valid annotation supported by rat experimental evidence (PMID:14986005).
Not a core function (intestine/kidney are primary sites) but represents
an established secondary physiological role.
supported_by:
- reference_id: PMID:14986005
supporting_text: "The data suggest that SGLT1 participates in transport
of D-glucose across the blood-brain barrier"
# --- Chloride transmembrane transport (ISO) ---
- term:
id: GO:1902476
label: chloride transmembrane transport
evidence_type: ISO
original_reference_id: GO_REF:0000121
negated: true
review:
summary: >-
ISO annotation for chloride transport. This is unexpected - SGLT1 is not
known as a chloride transporter. May be an erroneous annotation.
action: UNDECIDED
reason: >-
SGLT1 is a Na+/glucose symporter, not a chloride transporter. The basis for
this annotation is unclear. Would need to trace the original evidence from
the ortholog to evaluate. Marking as undecided pending clarification.
# --- Alpha-glucoside transport (ISO) ---
- term:
id: GO:0000017
label: alpha-glucoside transport
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation for alpha-glucoside transport. SGLT1 transports monosaccharides,
not glucosides (which typically refers to disaccharides).
action: MARK_AS_OVER_ANNOTATED
reason: >-
SGLT1 transports D-glucose and D-galactose (monosaccharides), not alpha-glucosides
like maltose or sucrose. This term is misleading for SGLT1's actual substrate
specificity.
# --- Carbohydrate utilization (IDA) ---
- term:
id: GO:0009758
label: carbohydrate utilization
evidence_type: IDA
original_reference_id: PMID:25592016
review:
summary: >-
IDA annotation from study on dietary regulation of Sglt1 gene expression.
The paper shows epigenetic regulation (H3K4 methylation) of Sglt1 in response
to high-starch diet, not direct SGLT1 involvement in carbohydrate utilization.
action: MODIFY
reason: >-
The paper demonstrates transcriptional regulation of Sglt1 by diet, not a
direct
role for SGLT1 protein in carbohydrate utilization. The appropriate process
would be related to glucose absorption/transport, not utilization.
proposed_replacement_terms:
- id: GO:0001951
label: intestinal D-glucose absorption
supported_by:
- reference_id: PMID:25592016
supporting_text: "Feeding rats the high-starch/low-fat diet induced mono-,
di-, and trimethylation of histone H3K4 on the promoter and transcribed
regions of the Si and Sglt1 genes"
# --- Metanephros development (ISO) ---
- term:
id: GO:0001656
label: metanephros development
evidence_type: ISO
original_reference_id: GO_REF:0000121
review:
summary: >-
ISO annotation for kidney development. SGLT1 is a glucose transporter that
is expressed during kidney development but is not known to have a developmental
signaling role.
action: UNDECIDED
reason: >-
The basis for this developmental annotation is unclear. SGLT1 may be expressed
during kidney development but is primarily a glucose transporter, not a
developmental regulator. Would need to evaluate the original ortholog evidence.
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with
GO terms
findings: []
- id: GO_REF:0000024
title: Manual transfer of experimentally-verified manual GO annotation data
to orthologs by curator judgment of sequence similarity
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000043
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword
mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular
Location vocabulary mapping
findings: []
- id: GO_REF:0000108
title: Automatic assignment of GO terms using logical inference, based on
inter-ontology links
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning
models
findings: []
- id: GO_REF:0000121
title: RGD ISO annotations to rat from other mammalian species
findings: []
- id: PMID:11831390
title: The apical localization of SGLT1 glucose transporter is determined by
the short amino acid sequence in its N-terminal domain.
findings:
- statement: N-terminal domain (first 19 amino acids) determines apical
localization in MDCK cells
supporting_text: "The products of N-terminal deletion clones up to the 19th
amino acid were localized at the apical plasma membrane, whereas the products
of N-terminal 20- and 23-amino-acid deletion clones were localized along
the entire plasma membrane."
- statement: D28 mutations cause cytoplasmic retention
supporting_text: "The products of D28N and D28G clones were localized in the
cytoplasm, showing that the aspartic acid-28 may be essential for the delivery
of SGLT1 to the plasma membrane."
- id: PMID:14986005
title: Localization of the Na+-D-glucose cotransporter SGLT1 in the
blood-brain barrier.
findings:
- statement: SGLT1 located in luminal membrane of brain capillary
endothelial cells
supporting_text: "Immunostaining suggested that SGLT1 is located in the luminal
membrane of the endothelial cells and in intracellular vesicles."
- statement: Also found in intracellular vesicles
supporting_text: "Immunostaining suggested that SGLT1 is located in the luminal
membrane of the endothelial cells and in intracellular vesicles."
- statement: SGLT1 mRNA upregulated after brain ischemia
supporting_text: "1 day after a transient occlusion of the right middle cerebral
artery, SGLT1 mRNA was detected in capillaries of both brain hemispheres."
- id: PMID:15829715
title: The endogenous CXXC motif governs the cadmium sensitivity of the
renal Na+/glucose co-transporter.
findings:
- statement: SGLT1 is a target for Cd2+ toxicity via CXXC motif
supporting_text: "the renal brush-border membrane Na+/glucose co-transporter-1
(SGLT1) is a molecular target for Cd2+ toxicity"
- statement: Demonstrated Na+/glucose cotransport activity
supporting_text: "Cd2+ acted as a noncompetitive, partial inhibitor of methyl-D-glucopyranoside
uptake in vesicles from COS-7 cells transiently expressing SGLT1"
- id: PMID:16204409
title: Rat renal glucose transporter SGLT1 exhibits zonal distribution and
androgen-dependent gender differences.
findings:
- statement: SGLT1 localized to S3 segment of proximal tubule
supporting_text: "the expression of SGLT1 is represented by a 75-kDa protein
localized largely in the PT S3 segments"
- statement: Gender differences in expression (female > male)
supporting_text: "In tissue cryosections, the antibody strongly stained BBM
of the S3 PT segments in the OS and medullary rays (F > M)"
- statement: Androgen-dependent regulation
supporting_text: "castration upregulated, whereas treatment of castrated rats
with testosterone, but not with estradiol or progesterone, downregulated
the 75-kDa protein"
- id: PMID:17090404
title: Asymmetric subcellular distribution of glucose transporters in the
endothelium of small contractile arteries.
findings:
- statement: SGLT1 present in vascular endothelium
supporting_text: "We identified GLUT-1 to -5 and SGLT-1 in the endothelial
cells of all three vascular beds."
- statement: Clusters at cell-cell junctions
supporting_text: "Clusters of the glucose transporter isoforms were found
at a high density in proximity to the cell-to-cell junctions."
- id: PMID:17272350
title: 'Apical GLUT2 and Cav1.3: regulation of rat intestinal glucose and calcium
absorption.'
findings:
- statement: SGLT1 at brush border membrane of jejunum
supporting_text: "Western blotting showed that in each case there was a significant
decrease in apical GLUT2 level, but no change in SGLT1 level."
- statement: SGLT1 transport initiates GLUT2 insertion
supporting_text: "We have proposed a model of intestinal glucose absorption
in which transport by SGLT1 induces rapid insertion and activation of GLUT2
in the apical membrane"
- statement: SGLT1 component is phloretin-insensitive
supporting_text: "the phloretin-insensitive SGLT1 component of glucose absorption"
- id: PMID:25592016
title: Induction of histone H3K4 methylation at the promoter, enhancer, and
transcribed regions of the Si and Sglt1 genes in rat jejunum in response
to a high-starch/low-fat diet.
findings:
- statement: Sglt1 gene expression induced by high-starch diet
supporting_text: "induction of Si and Sglt1 gene expression in rat jejunum
by a high-starch/low-fat diet intake is positively associated with histone
H3K4 methylation"
- statement: Epigenetic regulation via H3K4 methylation
supporting_text: "Feeding rats the high-starch/low-fat diet induced mono-,
di-, and trimethylation of histone H3K4 on the promoter and transcribed
regions of the Si and Sglt1 genes"
- id: file:rat/Slc5a1/Slc5a1-deep-research-falcon.md
title: Deep research report on Slc5a1
findings: []
core_functions:
- description: >-
Primary molecular function - electrogenic Na+-coupled D-glucose symporter with
2:1 Na+:glucose stoichiometry
molecular_function:
id: GO:0005412
label: D-glucose:sodium symporter activity
directly_involved_in:
- id: GO:0001951
label: intestinal D-glucose absorption
- id: GO:0035623
label: renal D-glucose absorption
locations:
- id: GO:0016324
label: apical plasma membrane
- id: GO:0031526
label: brush border membrane
- description: >-
Co-transports D-galactose with sodium using same mechanism as glucose transport
molecular_function:
id: GO:0015371
label: galactose:sodium symporter activity
directly_involved_in:
- id: GO:0015757
label: galactose transmembrane transport
locations:
- id: GO:0016324
label: apical plasma membrane
- description: >-
Acts as water channel with high conductivity comparable to aquaporins
molecular_function:
id: GO:0005372
label: water transmembrane transporter activity
directly_involved_in:
- id: GO:0035377
label: transepithelial water transport
locations:
- id: GO:0016324
label: apical plasma membrane